Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples